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Abstract 
Background: Rhipicephalus microplus is a hard tick species that has a high impact on cattle health and production 
in tropical and subtropical regions. Recently, ribosomal DNA and morphological analysis resulted in the reinstate-
ment of R. australis as a separate species from R. microplus. Both feed on cattle and can transmit bovine pathogens 
such as Anaplasma and Babesia species. The current treatment with acaricides is becoming increasingly less effective 
due to the emergence of resistant tick strains. A promising alternative can be found in the form of anti-tick vaccines. 
The available commercial vaccines can be used to control tick infestation, but the lack of a knockdown effect (> 90% 
reduction in tick numbers as seen with effective acaricides) hampers its widespread use, hence higher efficacious 
vaccines are needed. Instead of searching for new protective antigens, we investigated the efficacy of vaccines that 
contain more than one (partially) protective antigen. For screening vaccine formulations, a previously developed in 
vitro feeding assay was used in which R. australis larvae are fed sera that were raised against the candidate vaccine 
antigens. In the present study, the efficacy of the Bm86 midgut antigen and the cytosolic Subolesin (SUB) antigen 
were evaluated in vitro.
Results: Antiserum against recombinant Bm86 (rBm86) partially inhibited larval engorgement, whereas antiserum 
against recombinant SUB (rSUB) did not have any effect on feeding of larvae. Importantly, when larvae were fed a 
combination of antiserum against rBm86 and rSUB, a synergistic effect on significantly reducing larval infestations was 
found. Immunohistochemical analysis revealed that the rBm86 antiserum reacted with gut epithelium of R. australis 
larvae, whereas the antiserum against rSUB stained salivary glands and rectal sac epithelium.
Conclusions: Combining anti-Bm86 and anti-subolesin antibodies synergistically reduced R. australis larval feeding 
in vitro. Rhipicephalus australis is a one host tick, meaning that the larvae develop to nymphs and subsequently adults 
on the same host. Hence, this protective effect could be even more pronounced when larvae are used for infestation 
of vaccinated cattle, as the antibodies could then affect all three developmental stages. This will be tested in future in 
vivo experiments.
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Background
Rhipicephalus microplus is a hard tick that has a major 
impact on cattle health in tropical and subtropical 
regions. Tick attachment and feeding on cattle has a 
direct negative effect on cattle production [1]. Recently, 
ribosomal DNA and morphological analysis resulted in 
the reinstatement of R. australis as a separate species 
from R. microplus [2]. Next to production loss through 
feeding, ticks can transmit a range of diseases, includ-
ing anaplasmosis and babesiosis. It is therefore of great 
importance to control tick infestations to ensure live-
stock health, productivity and the livelihood of rural 
smallholder communities. To date, tick control heavily 
depends on the use of tick-resistant breeds and treat-
ment of susceptible breeds with acaricides, but tick 
resistance to these acaricides is becoming problematic 
[3].
An alternative to acaricide treatment could be vac-
cination with tick antigens. Early studies have shown 
that vaccination with crude tick antigen preparations 
was indeed able to induce antibodies and interfere with 
feeding and subsequent further development, thereby 
reducing tick infestation [4]. However, preparation of 
crude tick extracts is cumbersome and not feasible for 
the development of a commercial anti-tick vaccine. With 
the arrival of recombinant protein techniques, single pro-
tein antigens could be evaluated for protective activity. 
This led to the commercial and industrial production of 
Bm86, a tick midgut antigen first described in 1989 [5] 
which forms the basis of two commercial anti-tick vac-
cines  (GavacTM, Heber Biotech; TickGard, Merck Animal 
Health) [6, 7]. The efficacy of these vaccines in the field 
was estimated on average 55% reduction of the number 
of engorged adult female R. microplus ticks, which ham-
pers its widespread use [6].
After the discovery of Bm86 and its success as the 
first recombinant anti-tick vaccine, numerous stud-
ies have been performed, identifying multiple tick anti-
gens as reviewed previously [8, 9]. From these reviewed 
antigens, Ribosomal protein P0 was shown to have the 
highest overall efficacy of 96% [10]. However, as experi-
mental vaccination studies with these antigens showed 
a maximal reduction of 70% on the number of engorged 
female adults, none of these appear to be a vast improve-
ment over the current Bm86-based commercial vaccines 
nor approaching the efficacy of acaricides. Vaccination 
with partially purified tick extracts increased protection 
against R. microplus compared to Bm86 alone, indicating 
that the effect of Bm86-based vaccines could be increased 
through the addition of other tick antigens [11]. Hence, 
it seems more feasible to build on Bm86-based vaccines 
and increase their anti-tick efficacy by optimizing their 
formulation.
A more recently described antigen is Subolesin (SUB). 
It was discovered in 2003 through cDNA Expression 
Library Immunization of an I. scapularis derived IDE8 
embryonic cell line and subsequent Expressed Sequence 
Tag analysis [12] under the name of 4D8, later renamed 
Subolesin [13]. Phylogenetic analysis showed that SUB 
is an orthologue of Akirin [14]. Akirin is involved in the 
innate immune response of Drosophila melanogaster and 
is thought to function as a transcription factor in NF-κB 
dependent gene expression in insects and mammals [15]. 
Knock out of the SUB gene in RNAi experiments showed 
degeneration of salivary glands, midgut and reproduc-
tive organs [13]. RNAi of SUB showed a negative effect 
on tick weight and high reduction in tick progeny after 
feeding for multiple hard tick species [13, 16]. It has also 
been shown that RNAi with SUB reduced R. microplus 
infestation rate, tick weight and oviposition, whereas vac-
cination only affected R. microplus infestation rate and 
oviposition [17, 18].
Currently, vaccination-challenge trials in cattle are 
being used to evaluate and select R. microplus and R. 
australis candidate vaccine antigens. However, these 
experiments are costly, time consuming and are under 
limitation due to their negative impact on animal welfare. 
An in vitro feeding model for R. australis is an attrac-
tive alternative to evaluate the anti-tick effect of immune 
sera. There have been multiple reports of the use of in 
vitro feeding for ticks in literature [19–31]. There are 
two methods to feed ticks in vitro; capillary feeding and 
membrane feeding. Using capillary feeding, ticks are fed 
to repletion by placing capillary tubes over the hypos-
tome [19–21]. This technique is limited to the feeding of 
semi-engorged adult ticks as the ticks mouthparts need 
to be large enough to fit the capillary tube and ticks have 
to be very eager to imbibe blood. Membrane feeding tries 
to mimic the natural situation where ticks attach to either 
animal skin or an artificial membrane [22–25]. Depend-
ing on the membrane used, membrane feeding can be 
used for larval and nymphal ticks as well [26–28]. In both 
systems, ticks are fed naïve bovine blood (defibrinated or 
supplemented with anti-coagulants) and when in vitro 
efficacy of tick antigens are tested, specific antibodies 
or anti-serum was added. It is known that natural tick 
immunity consists of both humoral and cellular immune 
components. However, it can be partially transferred by 
antibodies alone. This led Evin & Kemp to postulate that 
an anti-tick vaccine should consist of antigens that can be 
targeted by antibodies and the formation of the antibody-
antigen complex should disrupt vector biology [32–34]. 
As defibrinated blood comes from naïve animals and the 
specific anti-serum does not contain immune cells, any 
observed anti-tick effect in vitro would, therefore, be 
highly antibody mediated. Consequently, any observed 
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anti-tick effect with in vitro feeding could be an under-
estimation of an anti-tick effect in vivo as cellular and 
humoral immune components interplay in vivo. In vitro 
feeding of larvae with small hypostomes as R. microplus 
through an artificial membrane proved to be highly chal-
lenging. Only recently we described the development 
of an in vitro feeding system for R. australis larvae that 
can be used to evaluate the inhibitory activity of antisera 
against tick antigens [35]. Here we evaluated the in vitro 
effect of antisera against Bm86, antisera against SUB, and 




Tick larvae were obtained from a colony of R. australis 
that was routinely passaged on Holstein calves (Merck 
Animal Health Innovation GmbH, Schwabenheim, Ger-
many). Fully engorged female ticks were collected from 
the calves and allowed to oviposit in Petri dishes. The 
resulting egg-masses were collected in laboratory tubes 
and allowed to hatch at 22 °C and 90% humidity. Four to 
six-week-old R. microplus larvae were used in the feeding 
experiments.
Tick naïve bovine serum
For the production of normal serum, blood from healthy 
tick naïve Holstein Friesian cattle was collected in BD 
Vacutainer® Plus plastic serum tubes. Blood was allowed 
to clot for 1 h at 37 °C, centrifuged for 15 min at 1000×g, 
serum was removed and stored at − 20 °C.
Antigen production, vaccination and serum collection
Recombinant Bm86 was produced in the Baculovirus 
expression system as described before [35]. Recombinant 
SUB was produced in E. coli, inclusion bodies denatured 
with 6M Ureum buffer and SUB was subsequently puri-
fied using a HIS-trap column (Profinia IMAC cartridge, 
Biorad, California, USA) and dialysed against 50 mM 
MES buffer (Fig.  1). Production of recombinant protein 
was confirmed by western blot with rabbit anti-rBm86 
(Pichia pastoris-produced) antiserum (1:100) and with a 
mouse monoclonal antibody (MSD Animal Health, Box-
meer, Netherlands) against poly-histidine  (His6-tail) for 
isolated rSUB-HIS6. Antigen-specific bovine serum was 
produced as follows: five Friesian Holstein cattle were 
subcutaneously vaccinated 2 times at a 3-week interval in 
the neck region with either Bm86 or SUB in water in oil 
adjuvant (Montanide ISA 50V2, Seppic, Paris, France).
Two weeks after the last vaccination with each antigen, 
blood was collected for serum production. Serum was 
pooled before feeding and antibody reactivity was quan-
tified through ELISA (see below).
Bm86 ELISA
Anti-Bm86 bovine serum titers were tested in a sandwich 
ELISA. In short, purified IgG from rabbit anti-rBm86 
(Pichia pastoris-produced) antiserum (5 µg/ml in bicar-
bonate/carbonate coating buffer) was coated overnight 
on a Greiner F ELISA plate at room temperature. The 
wells were subsequently blocked for 1 h with 200 µl/well 
1% w/v bovine serum albumin (BSA) in 0.04 M isotonic 
PBS at 37  °C. Next, Baculovirus-produced rBm86 was 
added to the plate (0.12 µg/ml in 1% w/v BSA in EIA-
tween80 buffer, 100 µl/well) and left to incubate for 2 h 
at 37 °C. Vaccinated cattle serum was diluted [in 1% w/v 
BSA in GLD/1 buffer supplemented with 10% (v/v) naïve 
dog serum] and 100  µl/well subsequently added to the 
plate for 1 h incubation at 37  °C. Goat anti-bovine IgG-
HRP (Jackson ImmunoResearch Inc., Westgrove, USA) 
was 2500 times diluted in 1% w/v BSA in EIA-tween80 
buffer and 100 µl/well added to incubate for 1 h at 37 °C. 
Finally, 100 µl/well substrate (185 µl TMB and 1 ml UP-
buffer in 10  ml water for injection) was added and left 
to incubate for 15 min in the dark at room temperature. 
The reaction was stopped with 50 µl/well 4N  H2SO4 and 
OD was measured at 450 nm. Antibody titres were cal-
culated as end point titres (Cut off is Bmin*2) using the 
ABend Vertical CBA v2.29 software package (MSD ani-
mal Health, Boxmeer, Netherlands).
SUB ELISA
Antibody titres against rSUB-HIS6 recombinant anti-
gen were determined using a sandwich ELISA. Briefly, 
Greiner F ELISA-plates were coated overnight with a 
mouse monoclonal antibody (MSD Animal Health, Box-
meer, Netherlands) against poly-histidine  (His6-tail). 
Plates were washed and blocked with 1% w/v BSA in 0.04 
M isotonic PBS and a standard amount of rSUB-His6 
antigen in EIA-tween 80 was added to the plates. After 
incubation three-fold serial dilutions of serum samples in 
1% w/v BSA and 10% v/v naïve dog serum in GLD1 buffer 
was added. Next, total bound immunoglobulin antibodies 
were detected by incubation with a secondary antibody 
goat-anti-bovine IgG conjugated with peroxidase. Finally, 
100 µl/well substrate (185 µl TMB and 1 ml UP-buffer in 
10 ml water for injection) was added and left to incubate 
for 15  min in the dark at room temperature. The reac-
tion was stopped with 50 µl/well 4N  H2SO4 and OD was 
measured at 450 nm. Antibody titres were calculated as 
end point titres (Cut off is Bmin*2) using the ABend Ver-
tical CBA v2.29 software package (MSD Animal Health).
Immunohistochemistry
Unfed R. australis larvae were fixed with 4% v/v for-
maldehyde, later dehydrated for 30 min at each of the 
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following ethanol concentrations, 70%, 80%, 90% and 
100% v/v, routinely embedded in paraffin wax and 3–5 
µm sections were made. Hematoxylin and eosin stain-
ing was performed following routine histological pro-
cedures. Sections used for labeling with anti-rSUB 
antibodies were blocked with 1% w/v BSA, incubated 
with anti-rSUB rabbit serum (1:400). Naïve rabbit 
serum (1:400) was used as a control. Bm86 antigen 
detection was performed by labeling with anti-rBm86 
antibodies after pre-incubation of the thin sections 
with proteinase K for 30 min. Slides were subsequently 
blocked with 1% w/v BSA, incubated with anti-rBm86 
rabbit serum (1:400). As a control naïve rabbit serum 
(1:400) was used.
Artificial tick feeding
The feeding units were used as described before [35]. 
Feeding membranes were made from baudruche mem-
branes of less than 30 µm thickness (Preservation Equip-
ment Ltd, Diss, United Kingdom) treated with silicone 
to add strength and flexibility. Silicone mixture was pre-
pared: 15  g Wacker silicone E4, 9  g Silicone oil AP 200 
(Sigma-Aldrich, St. Louis, Missouri, United States) and 
5.8 g Hexane. After carefully mixing, 1.5 mg silicone mix-
ture per  cm2 was applied with a gloss paint roller. The 
siliconized membrane was left to polymerize overnight 
at room conditions. Final membrane thickness was meas-
ured with a micrometer. Membranes with a maximal 
thickness of 40 µm were used for feeding.
Fig. 1 Recombinant Bm86 and subolesin and determination of antigen specific antibody titers. a Coomassie staining (left) and Western blot using 
anti-HIS mouse IgG (right) of purified subolesin (SUB) using a 4–20% Bis-Tris gel. b Anti-SUB antibody titration by sandwich ELISA; recombinant 
SUB was captured with anti-HIS mouse IgG and pooled SUB vaccinated cow serum was diluted to calculate endpoint titers. End-point titer cut-off 
(Bmin*2) is indicated by dashed line. c Coomassie staining (left) and Western blot using Bm86 (P. pastoris-produced) specific rabbit IgG (right) of 
recombinant Bm86. d Anti-Bm86 antibody titration by sandwich ELISA adapted from Trentelman et al. [35]. Bm86 (baculovirus produced) was 
captured with Bm86 (P. pastoris-produced) specific rabbit IgG and pooled SUB vaccinated cow serum was diluted to calculate endpoint titers. End 
point titer cut-off (Bmin*2) is indicated by dashed line
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The feeding membrane was clamped in the feeding 
unit and 75  µl methanol bovine hair extract was added 
to each well and left to dry for 30 minutes at room tem-
perature in order to apply bovine scent to the siliconized 
side of the feeding membrane. Next, the unit was turned 
upside down and R. australis larvae were added to the 
wells (approximately 100 larvae per well). Netting was 
used to cover the plate and the lower plate was imme-
diately mounted using the bolts to contain the larvae. 
The unit was then put upright, which stimulated contact 
between the serum and the larvae; as a result of their 
questing behavior larvae crawled up to the underside of 
the membrane.
The wells of the upper plate with the baudruche side 
of the feeding membrane at the bottom were disinfected 
using 70% ethanol and left to dry. Before serum was 
added to the in vitro feeding system, each 10 ml of serum 
was supplemented with 5 µl gentamycin (Sigma-Aldrich, 
10 mg/ml). Six hundred µl serum was added to each well 
and replaced with fresh serum twice daily.
Serum samples were pre-warmed at 37  °C and subse-
quently added to the wells of the upper plate. The upper 
plate was sealed with an ELISA plate cover or Parafilm. 
The unit was placed in a  CO2 incubator at 37  °C, 90% 
RH and 5%  CO2 (as a feeding stimulus) for 48 h to allow 
larvae to feed. Feeding was stopped by placing the feed-
ing unit overnight at − 20  °C thus freezing the larvae. 
The percentage of larvae that were engorged (having 
an enlarged abdomen of at least 2 times the size of the 
dorsal shield) was determined visually using a stereomi-
croscope. The studies were performed blind in that the 
evaluator had no knowledge about the distribution of 
the test materials over the plate (see statistical evaluation 
below).
Statistical evaluation
In order to identify statistically significant results, sam-
ples were tested in six-fold. The samples were allocated 
to the feeding unit such that they were evenly distrib-
uted over the plate. This was done to prevent plate-posi-
tion effects on feeding. The code was kept secret to the 
evaluator until after determination of the engorgement 
rate in each well. From the individual values, the average 
engorgement rate was calculated. Differences between 
engorgement rates obtained with different test materials 
were analyzed for statistical significance using one-way 
ANOVA (Graphpad Prism 5, Graphpad Software Inc.).
Results
Production of antisera against rBm86 and rSUB in calves
Friesian Holstein cattle were vaccinated with rBm86 
or rSUB and the collected serum was tested for antigen 
specificity and antibody titers. Western blot analysis 
showed that bovine serum against rSUB or rBm86 both 
were specific to their respective recombinant antigens; 
the anti-rBm86 antiserum stained a protein at Mw 
100kDa, and the anti-rSUB antiserum stained a protein 
at Mw 25kDa and a protein at Mw 50kDa, which could be 
a doublet of the Mw 25kDa protein (Fig. 1a, c). Specific 
antibody levels were subsequently quantified as endpoint 
titers (cut-off Bmin*2) for each specific antigen using a 
sandwich ELISA. The antibody endpoint titers were cal-
culated as 2log values; generated anti-rBm86 serum had 
an endpoint titer of 17.0 (Fig. 1d). Vaccination with rSUB 
resulted in a 2log antibody end titer of 17.8 (Fig. 1b).
Immunohistochemistry
Immunochemistry was used to visualize which tissues 
were recognized by antibodies against rBm86 and rSUB. 
Microscopic slides of whole unfed R. australis were incu-
bated with anti-serum directed against each antigen. 
Antibodies against Bm86 were found to bind specifically 
to gut epithelium (Fig. 2). Staining of unfed R. australis 
larvae with antibodies directed against subolesin showed 
that anti-rSUB antibodies bound specifically to the acini 
of the salivary glands and to the epithelium of the rectal 
sac (Fig. 3a, c). Reactivity in the acini could be observed 
throughout the cytoplasm and the globular pattern of 
staining suggest that the antibodies might bind to small 
granules within the acini (Fig. 3b, d).
Effect of anti‑rBm86 and anti‑rSUB bovine sera on in vitro 
tick feeding
To determine the effect of the monospecific antisera 
against rBm86 and rSUB on engorgement, antisera were 
fed in vitro to 4–6 week-old R. australis larvae in six rep-
licates. Of the larvae that were fed control (undiluted 
tick naïve bovine) serum, on average 44.3% had fed (data 
not shown). Feeding of larvae with undiluted antiserum 
against rSUB did not affect feeding as compared to the 
control serum (5% reduction; Fig. 4). However, larvae that 
had been fed with undiluted antiserum against rBm86 
exhibited reduced feeding (39% reduction), but this dif-
ference did not reach statistical significance. Importantly, 
when feeding a mixture of equal volumes of serum raised 
against rBm86 and rSUB (hence each was tested at one 
time dilution) larval feeding was statistically significantly 
reduced by 62.7% (P = 0.024) compared to control serum 
(Fig. 4).
In order to compare the effect of the two monospe-
cific antisera with the mixture of the two sera at a simi-
lar dilution, the monospecific sera were one time diluted 
with tick naïve bovine serum. The mean feeding of larvae 
that were fed tick naïve bovine serum was 39.5% (control 
group). When larvae were fed either one-time diluted 
anti-rBm86 antiserum or one-time diluted anti-rSUB 
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antiserum, no inhibition of feeding was found (Fig.  5). 
However, when larvae were fed the mixture of anti-
rBm86/anti-rSUB antiserum, feeding was reduced by 
26.7%. Although the observed effect was again highest 
with the mixture of the monospecific antisera, this differ-
ence did not reach statistical significance in this experi-
ment (P = 0.095).
Discussion
In search for an improved anti-tick vaccine, the effec-
tiveness of vaccine formulations that contain two or 
more tick antigens, which have shown partial protec-
tion when used as single-antigen vaccines, are being 
evaluated. The basis of such vaccine is the recombinant 
R. microplus midgut antigen rBm86 that is used in com-
mercially available vaccines. Early experiments in immu-
nized cattle have shown that protection is related to the 
antibody titer against rBm86 [36, 37], and in vitro feed-
ing experiments with adult R. microplus showed that 
serum or purified immunoglobulins (Ig) from immu-
nized cattle reduced the engorgement rate and oviposi-
tion in a high percentage of the ticks by damage of the 
midgut [38]. Similarly, vaccination of cattle with rSUB, 
a cytoplasmic and nuclear antigen from R. microplus 
ticks, induced partial protection that could be related to 
the level of anti-rSUB antibodies [39]. Before embarking 
on vaccination-challenge experiments in cattle to evalu-
ate the efficacy of vaccination against both recombinant 
antigens, we studied the effect of anti-rBm86 and rSUB 
antibodies in vitro using a recently developed technique 
that allows feeding R. australis larvae with blood and/or 
serum [35]. Although the assay allows detecting statisti-
cally significant differences, variability can occur due to 
a number of factors such as tick age and condition, and 
batch differences of membranes and attractants. This can 
be overcome to some extent by increasing the number 
of replicates in the feeding assay. The results presented 
here show that the number of R. australis larvae able to 
feed is reduced when feeding undiluted anti-rBm86 anti-
serum from immunized cattle compared to tick naïve 
bovine serum, which is in line with earlier results [35]. 
When the Bm86 antiserum was diluted once with tick 
naïve bovine serum the effect on tick feeding was lost. 
This is reminiscent of the work of Kemp and co-workers, 
who showed that an increase of anti-Bm86 IgG con-
centration to a concentration of twice that found in the 
original serum, increased the level of adult tick damage 
in vitro significantly [38]. Apparently, the effect of anti-
Bm86 serum on feeding (and/or gut damage in vitro) is 
an almost a “yes” or “no” effect. In the same paper Kemp 
et  al. show that antibodies can independently induce 
damage in feeding ticks. As antibodies block endocytosis 
Fig. 2 Localization of Bm86 in unfed R. australis larvae. Cross sections (20× magnification) of larvae stained with: a rabbit anti-Bm86 serum (1:400 
diluted) and b naïve rabbit serum (1:400 diluted). Sections were pre-treated with proteinase K for 30 min before antibody incubation. Antibodies 
bound specifically to midgut epithelium (indicated with arrows). Abbreviations: Syn, synganglion; MG, midgut; RS, rectal sac; A, acinus
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of fluorescein-labeled BSA by gut cells in vitro [5], one 
might hypothesize that blocking endocytosis adversely 
affects further engorgement of the larvae. Feeding larvae 
with undiluted anti-rSUB antiserum did not affect the 
feeding. Surprisingly, when larvae were fed anti-rBm86 
serum that was 1:1 diluted with anti-rSUB antiserum, a 
62.7% reduction of feeding was observed that was statis-
tically significant (P < 0.05). This suggests that the action 
of anti-rBm86 antibodies allowed an additional and 
highly synergistic effect of anti-rSUB antibodies on tick 
feeding. It could be hypothesized that damage of gut epi-
thelial cells, or lysis, exerted by anti-rBm86 antibodies is 
a prerequisite for antibodies against rSUB to exert their 
effect in ticks fed in vitro. Alternatively, the effect of anti-
rBm86 could be catalyzed by the presence of anti-rSUB 
antibodies through an as yet unknown mechanism. Any 
explanation is at this point highly speculative.
In order to determine the localization of the proteins 
that were recognized by anti-rBm86 and anti-rSUB 
antibodies, immunohistochemistry was used. Due to 
the high background upon incubation with a conjugate 
against bovine Ig (data not shown) we used polyclonal 
rabbit sera that was raised against the two recombi-
nant proteins instead of the bovine antisera. Antibod-
ies against rBm86 were found to bind specifically to gut 
epithelium as has been reported previously, and did not 
stain the acini of the salivary glands [38, 40, 41]. In con-
trast, antibodies against rSUB reacted with some, but not 
all, of the acini of the salivary glands of unfed R. australis 
larvae. Reactivity in the acini was observed throughout 
the cytoplasm. This was unexpected as subolesin, which 
is a homologue of akirin, is thought to be an intranu-
clear protein [14, 15]. Consequently, subolesin does not 
seem to be present only in the nucleus, or the observed 
Fig. 3 Localization of SUB in unfed R. australis larvae with polyclonal anti-SUB rabbit serum. a A cross-section (20× magnification) of a larva stained 
with rabbit anti-SUB serum (1:400 diluted). The square indicates the area depicted in higher magnification (40×) in b. IgG showed binding in the 
acini of the salivary glands, throughout the cytoplasm and within granules (indicated with arrows). c A cross section of a larva (20× magnification) 
stained with naïve rabbit serum (1:400 diluted). The square indicates the area depicted in higher magnification (40×) in d. d Details of the salivary 
glands are depicted on the right side (40× magnification). In contrast to the polyclonal anti-SUB serum no IgG binding could be observed in the 
salivary glands after incubation with naïve rabbit serum. Abbreviations: Syn, synganglion; MG, midgut; RS, rectal sac; A, acinus
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reaction outside the nucleus might be explained by cross-
reactivity of the anti-rSUB antibodies with an epitope on 
another protein. However, as the presence of SUB in the 
cytoplasm of cells in tick salivary glands was described 
previously for adult R. microplus [30], it is most likely 
that indeed SUB is also present in the cytoplasm of unfed 
larval salivary glands. Although the exact mechanism for 
the observed synergistic effect on larval feeding in vitro 
is unknown, it could be related to the different tick tis-
sues targeted by each antibody; in R. australis larvae 
anti-rBm86 antibodies react with the gut epithelium and 
anti-rSUB antibodies react with the cytoplasm of acini in 
the salivary glands and with the epithelium of the rectal 
sac. While it is clear that biological variation can induce 
differences in effect sizes between in vitro assays, the pre-
sented in vitro reduction of the larval feeding gives high 
expectations for studying the efficacy of these antigens 
on R. australis infestation in vivo. Differences in effect 
sizes between in vitro assays, shows biological variation 
between tick batches. While feeding success for all con-
trol groups was similar, on average 40% of larvae attached 
and fed, expression levels of the target antigens might 
differ between ticks. For instance, for Bm86 it is known 
that expression levels are low in unfed larvae and shows 
relatively high variation compared to later life stages 
[42]. Differences in in vitro effect size due to biological 
variation in larvae would therefore likely to be less pro-
nounced in the in vivo situation where all three life stages 
are involved. In vivo infestation experiments with R. aus-
tralis and R. microplus on cattle span the entire life-cycle 
of the tick and therefore measures the summed effect of 
the tested vaccine on larval, nymphal and adult life stages 
and their respective molting periods. Since larvae are 
only the first stage of the life-cycle of R. australis and R. 
microplus and they only imbibe small amounts of blood 
compared to nymphal ticks and especially adult ticks, 
it might be very well possible that the combination of a 
vaccine targeting both Bm86 and subolesin will have a 
higher efficacy on these later stages.
Conclusions
To determine the potential protective effect of vaccines 
that contain a mixture of tick antigens, a 24-well in 
vitro feeding assay for R. australis larvae was used. It 
was found that feeding a combination of antisera rose 
against rBm86 and rSUB reduced the proportion of 
engorged larvae by 62.7% as compared to controls that 
received tick naïve bovine serum. As a result, a com-
bined vaccine containing rBm86 and rSUB is appears 
to be a highly promising formula for further in vivo 
testing.
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